Christine Gunther
Munich, BY 81377, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 10, 2019
Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma.
Journal: Oncotarget
Published: January 27, 2019
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial.
Journal: International journal of cancer
Published: December 17, 2018
Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 11, 2018
Mesenchymal Stromal Cells Protect Endothelial Cells from Cytotoxic T Lymphocyte-Induced Lysis.
Journal: Scandinavian journal of immunology
Published: April 13, 2016
Ligand-Modified Human Serum Albumin Nanoparticles for Enhanced Gene Delivery.
Journal: Molecular pharmaceutics
Published: July 29, 2015
Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.
Journal: Frontiers in immunology
Published: February 18, 2015
Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial.
Journal: BMC cancer
Published: September 30, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026